Pharma IQ to organize 4th Improving Solubility conference at The Park Hyatt in Philadelphia

Organized by Pharma IQ, a division of IQPC, the 4^th Improving Solubility conference will be held March 29-31, 2010 at The Park Hyatt in Philadelphia, PA. This forum brings together pharmaceutical researchers and scientists to uncover advances in enhancing solubility, amorphous forms, bioavailability & lipid-based formulation of drugs.

“Excellent networking and diverse sessions; good to have theoretical discourse.”

Since the number of poorly soluble drugs coming to market have increased, many pharmaceutical companies are working on new techniques to measure, predict and improve the bioavailability of compounds. However, it remains unclear which method will be widely adopted to build successful drug compounds and maximize time-to-market.

Leading pharmaceutical and research organizations, including AstraZeneca, Merck, Novartis, Pfizer, Sanofi-Aventis, Bristol-Myers Squibb, H. Lundbeck, Hoffman La-Roche and GlaxoSmithKline. will present case studies and solutions on:

• Nanocrystalline drug-polymer solid dispersions for poorly water-soluble drugs
• The role and function of solubility measurement from a central laboratory in drug discovery
• Implications of Biopharmaceutical Classification System (BCS): Solubility and permeability class on drug formulation
• Lipid-based drug delivery to effectively overcome physical and biological barriers
• Oral lipid-based formulations for the enhancement of poorly soluble compound delivery
• API crystal forms and their bioavailability
• Novel strategies for salt selection concerning solubility enhancement, salt stability and stabilization

Dr. Jeff Skell, Director of DMPK & Pharmaceutics, Drug & Biomaterial R&D at Genzyme and speaker at the 4^th Improving Solubility commented on the conference series, stating: “Excellent networking and diverse sessions; good to have theoretical discourse.”

Past speaker, Dr. Debra Walker, Research Fellow at Merck & Co. adds, “[The conference provides a] great mix of technical details plus examples.”

Exhibitors at the 4^th Improving Solubility conference include Eurand, CyDex Pharmaceuticals Inc, Catalent Pharma Solutions, Bend Research Inc, Aptuit, O’Brien Jones and others.